New York, NY – June 8, 2017 – Wall Street Corner Report
 
North American Cannabis Holdings (USOTC: USMJ) PPS and Puration, Inc. (USOTC: PURA) are currently rated as VERY BULLISH by Stock Technical Analysis (stockta.com) based on candlestick analysis.  The majority interest in both companies was just acquired by a private equity backed firm in the first step of a cannabis roll-up. The two companies will continue to trade independently.  No reverse split is planned.  PURA has indicated its 1st year post updated operational business plan implementation revenue forecast could double from $3 million to $6 million.  USMJ has indicated a similar revenue forecast increase from its original $2 million outlook. 
 
The Cannabis Report indicates “marijuana stocks are taking off:”

 

“The North American marijuana business posted a revenue of $6.7 billion in 2016 - 30% up on the previous year. With Canada set to legalise recreational use next year, the green rush shows no sign of slowing down.

The Cannabis Report analyzes the fundamentals of these relatively new companies and helps you to make the right trading decisions on the right companies at the right time.”

 
The Cannabis Report has published analysis of USMJ and several other  cannabis stocks to include GW Pharmaceuticals (GWPH) and Rocky Mountain High Brands (RMHB).
 
Wall Street Corner Report is the premier discovery site for promising, yet undiscovered small and micro-cap stocks featuring opportunities in an ethical, professional, and responsible manner. We're not fiendishly 'short' sighted nor are we here to dream the impossibly 'long' dream.  We take a practical view on the big ideas of well-intentioned management and look to profit on each reasonably achievable step the well intentioned mangers take toward their big ideas.
 

http://www.wallstreetcornerreport.com/more-news/
 
https://twitter.com/WallStCornerRpt
 
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

 

GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more GW Pharmaceuticals Charts.
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more GW Pharmaceuticals Charts.